Skip to content

A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation (Experiment 2)

A Non-invasive Intervention (BreEStim) for Management of Phantom Limb Pain (PLP) After Limb Amputation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04750538
Enrollment
17
Registered
2021-02-11
Start date
2021-04-02
Completion date
2023-05-19
Last updated
2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management

Keywords

Phantom Limb Pain, BreEStim

Brief summary

The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and conventional electrical stimulation (EStim) in management of neuropathic phantom limb pain in patients after limb amputation.

Interventions

DEVICEBreEStim 120

120 BreEStim stimuli will applied for about 10-15 minutes.

240 BreEStim stimuli will applied for about 20-30 minutes.

Sponsors

National Institute on Disability, Independent Living, and Rehabilitation Research
CollaboratorFED
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* has phantom limb pain (PLP) after amputation of one limb, upper or lower limb; * has chronic pain, \>3 months; * is stable on oral pain medications at least two weeks. (patients are allowed to continue their pain medications, i.e., no change in pain medications.)

Exclusion criteria

* currently adjusting oral pain medications for their PLP; * has pain, but not PLP (e.g., from inflammation at the incision wound of the residual limb); * has a pacemaker, or other metal and/or implanted devices; * has cognitive impairment from brain injury or are not able to follow commands, or to give consent; * has amputation in multiple limbs; * have asthma or other pulmonary diseases; * are not medically stable; * have preexisting psychiatric disorders; * alcohol or drug abuse; * have a history of seizures/Epilepsy, or taking benzodiazepines, anticonvulsants, and antidepressants.

Design outcomes

Primary

MeasureTime frameDescription
Change in Pain Level as Measured by the Visual Analog Scale (VAS).Baseline, 10 minutes after interventionVAS Scores are recorded from 0 to 10 with 0 being no pain and 10 being worst pain, a higher score indicating a higher level of pain. Change is reported as \[(VAS score at baseline) - (VAS Score 10 minutes after intervention)\] - a positive value indicates that the score (and pain level) decreased

Secondary

MeasureTime frameDescription
Change in Sensation Threshold on Amputated Limb Measured by Electrical Sensation Threshold (EST)Baseline, 5 minutes after interventionElectrical Sensation Threshold (EST) is the minimum electrical current intensity that a person can reliably perceive as a sensation on their skin. This threshold is self-reported by the subjects, and electrical intensity values are recorded when participants first detect the electrical stimulation. Change is reported as \[(EST at 5 minutes after intervention) - (EST at baseline)\] - a positive value indicates a decrease in sensation perception.
Change in Pain Threshold on Amputated Limb Measured by Electrical Pain Detection Threshold (EPT)Baseline, 5 minutes after interventionAn Electrical Pain Threshold (EPT) refers to the minimum intensity of electrical stimulation required to produce a perceptible pain sensation on a person's skin, essentially measuring the point at which an electrical current becomes painful. The EPT is self-reported by subjects when they feel the electrical intensity begins to cause pain. Change is reported as \[(EPT at 5 minutes after intervention) - (EPT at baseline)\] - a positive value indicates an increase in pain threshold.

Other

MeasureTime frameDescription
Change in Heart Rate Variability (HRV) Measured by Electrocardiogram (ECG)Baseline, 10 minutes after interventionHRV is a measure of the variation in time between each heartbeat. We use HRV to identify the autonomic nervous system changes after intervention treatment.

Countries

United States

Participant flow

Participants by arm

ArmCount
BreEStim 120, Then BreEStim 240
BreEStim is voluntary breathing controlled transcutaneous electrical nerve stimulation. 120 vs 240 BreEStim electrical stimuli will be compared to examine the impact of different stimuli dose on pain reduction in this experiment. BreEStim 120: 120 BreEStim stimuli will applied for about 10-15 minutes. BreEStim 240: 240 BreEStim stimuli will applied for about 20-30 minutes.
17
BreEStim 240, Then BreEStim 120
BreEStim is voluntary breathing controlled transcutaneous electrical nerve stimulation. 120 vs 240 BreEStim electrical stimuli will be compared to examine the impact of different stimuli dose on pain reduction in this experiment. BreEStim 120: 120 BreEStim stimuli will applied for about 10-15 minutes. BreEStim 240: 240 BreEStim stimuli will applied for about 20-30 minutes.
0
Total17

Baseline characteristics

CharacteristicTotalBreEStim 120, Then BreEStim 240
Age, Categorical
<=18 years
0 Participants0 Participants
Age, Categorical
>=65 years
3 Participants3 Participants
Age, Categorical
Between 18 and 65 years
14 Participants14 Participants
Race/Ethnicity, Customized
Asian
0 Participants0 Participants
Race/Ethnicity, Customized
Black or African American
6 Participants6 Participants
Race/Ethnicity, Customized
Hispanic or Latino
2 Participants2 Participants
Race/Ethnicity, Customized
Others
1 Participants1 Participants
Race/Ethnicity, Customized
White Non-Hispanic
8 Participants8 Participants
Region of Enrollment
United States
17 participants17 participants
Sex: Female, Male
Female
6 Participants6 Participants
Sex: Female, Male
Male
11 Participants11 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 170 / 17
other
Total, other adverse events
17 / 1717 / 17
serious
Total, serious adverse events
0 / 170 / 17

Outcome results

Primary

Change in Pain Level as Measured by the Visual Analog Scale (VAS).

VAS Scores are recorded from 0 to 10 with 0 being no pain and 10 being worst pain, a higher score indicating a higher level of pain. Change is reported as \[(VAS score at baseline) - (VAS Score 10 minutes after intervention)\] - a positive value indicates that the score (and pain level) decreased

Time frame: Baseline, 10 minutes after intervention

ArmMeasureValue (MEAN)Dispersion
BreEStim 120Change in Pain Level as Measured by the Visual Analog Scale (VAS).1.43 score on a scaleStandard Deviation 1.24
BreEStim 240Change in Pain Level as Measured by the Visual Analog Scale (VAS).1.71 score on a scaleStandard Deviation 1.39
Secondary

Change in Pain Threshold on Amputated Limb Measured by Electrical Pain Detection Threshold (EPT)

An Electrical Pain Threshold (EPT) refers to the minimum intensity of electrical stimulation required to produce a perceptible pain sensation on a person's skin, essentially measuring the point at which an electrical current becomes painful. The EPT is self-reported by subjects when they feel the electrical intensity begins to cause pain. Change is reported as \[(EPT at 5 minutes after intervention) - (EPT at baseline)\] - a positive value indicates an increase in pain threshold.

Time frame: Baseline, 5 minutes after intervention

ArmMeasureValue (MEAN)Dispersion
BreEStim 120Change in Pain Threshold on Amputated Limb Measured by Electrical Pain Detection Threshold (EPT)3.92 milliampere (mA)Standard Deviation 17.97
BreEStim 240Change in Pain Threshold on Amputated Limb Measured by Electrical Pain Detection Threshold (EPT)2.29 milliampere (mA)Standard Deviation 10.46
Secondary

Change in Sensation Threshold on Amputated Limb Measured by Electrical Sensation Threshold (EST)

Electrical Sensation Threshold (EST) is the minimum electrical current intensity that a person can reliably perceive as a sensation on their skin. This threshold is self-reported by the subjects, and electrical intensity values are recorded when participants first detect the electrical stimulation. Change is reported as \[(EST at 5 minutes after intervention) - (EST at baseline)\] - a positive value indicates a decrease in sensation perception.

Time frame: Baseline, 5 minutes after intervention

ArmMeasureValue (MEAN)Dispersion
BreEStim 120Change in Sensation Threshold on Amputated Limb Measured by Electrical Sensation Threshold (EST)0.95 milliampere (mA)Standard Deviation 4.06
BreEStim 240Change in Sensation Threshold on Amputated Limb Measured by Electrical Sensation Threshold (EST)3.43 milliampere (mA)Standard Deviation 11.57
Other Pre-specified

Change in Heart Rate Variability (HRV) Measured by Electrocardiogram (ECG)

HRV is a measure of the variation in time between each heartbeat. We use HRV to identify the autonomic nervous system changes after intervention treatment.

Time frame: Baseline, 10 minutes after intervention

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026